Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC.

ABSTRACT: Low skeletal muscle mass is a well-known prognostic factor for patients treated for a non-small-cell lung cancer by surgery or chemotherapy. However, its impact in patients treated by exclusive radiochemotherapy has never been explored. Our study tries to evaluate the prognostic value of low skeletal muscle mass and other antropometric parameters on this population. Clinical, nutritional and anthropometric date were collected for 93 patients treated by radiochemotherapy for a NSCLC. Anthropometric parameters were measured on the PET/CT by two methods. The first method was a manual segmentation at level L3, used to define Muscle Body Area (MBA_L3), Visceral Fat Area (VFA_L3) and Subcutaneous Fat Area (SCFA_L3). The second method was an software (Anthropometer3D

SUBMITTER: Mallet R 

PROVIDER: S-EPMC8137692 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature